Camber debuts generic Aubagio

Teriflunomide tablets are indicated for treating relapsing forms of multiple sclerosis, including clinically isolated syndrome, relapsing-remitting disease and active secondary progressive disease in adults.

Sandra Levy

3/13/2023

Camber is introducing teriflunomide tablets, which are the generic of Aubagio.

Teriflunomide tablets are indicated for the treatment of relapsing forms of multiple sclerosis, including clinically isolated syndrome, relapsing-remitting disease and active secondary progressive disease in adults.

[Read more: Camber intros generic Ranexa]

Teriflunomide tablets are available in 7 mg and 14 mg and are supplied in 30-ct. bottles.

[Read more: Camber launches generic Valcyte]

Walgreens buyout reportedly could result in three divisions

Walgreens’ three core segments—U.S. pharmacy retailer Walgreens, U.K.-based Boots and specialty unit Shields Health Solutions—could become three independent divisions, per a report.

Ulta Beauty sets date for experiential beauty event

Ulta Beauty World will take place on April 26 in San Antonio, Texas.

CVS Health to open smaller format stores

Each location will average less than 5,000 square feet and will feature a full-service pharmacy with limited over-the-counter products available for purchase.